Active Shortage

APO-TOBRAMYCIN

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-TOBRAMYCIN in Canada?

Yes. APO-TOBRAMYCIN 0.3% has an active shortage reported to Health Canada (last updated October 5, 2017).

Why is APO-TOBRAMYCIN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-TOBRAMYCIN be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file6 products

Affected strength0.3%

Last updated2017-10-05

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

SANDOZ TOBRAMYCIN

SANDOZ CANADA INCORPORATED

0.3% · DIN 02241755

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

TOBREXAN

NOVARTIS PHARMACEUTICALS CANADA INC

0.3% · DIN 02261243

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

TOBREX

NOVARTIS PHARMACEUTICALS CANADA INC

0.3% · DIN 00614254

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TOBRAMYCIN INJECTION USP

SANDOZ CANADA INCORPORATED

10MG · DIN 02241209

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

TOBRAMYCIN OPHTHALMIC SOLUTION USP 0.3%

BAUSCH & LOMB PHARMACEUTICALS INC.

3MG · DIN 02239148

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TOBI

BGP PHARMA ULC

300MG · DIN 02239630

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

DIN

02245698

Strength

0.3%

Dosage Form

SOLUTION

Route

OPHTHALMIC

Active Ingredient

TOBRAMYCIN

See all TOBRAMYCIN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2017-10-05

Active Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244